Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Mass Spectrometry and Drug Discovery

View through CrossRef
AbstractCombinatorial chemistry and high‐throughput screening have become the primary tools of the medicinal chemist in an effort to accelerate the pace of drug discovery. The goal of this new paradigm is to produce in a short time large numbers of synthetic organic compounds representing a great diversity of chemical structures through a process called combinatorial chemistry, and then quickly screen themin vitroagainst pharmacologically significant targets such as enzymes or receptors. As a result, lead compounds might emerge from such combinatorial chemistry drug discovery programs in a few weeks instead of several years. Although a variety of spectroscopic and chromatographic techniques are being used to support drug discovery in various capacities, only high performance liquid chromotography (HPLC) combined with mass spectrometry (LC‐MS and LC‐MS‐MS) is compatible with virtually all drug‐like molecules. In addition to providing a universal means to characterize and distinguish drugs and drug candidates based on both molecular weight and structural features, mass spectrometry provides high throughput. With the development of routine LC‐MS interfaces and ionization techniques such as electrospray and atmospheric pressure chemical ionization, mass spectrometry has also become an ideal HPLC detector for the analysis of combinatorial libraries. Furthermore, a variety of mass spectrometry–based screening assays have been developed to address the need to screen complex mixtures of combinatorial compounds as well as to screen natural product extracts as a means of expanding the molecular diversity of drug leads. The use of mass spectrometry in support of combinatorial library synthesis and purification is addressed in this chapter, as well as screening applications such as frontal affinity chromatography–mass spectrometry, gel permeation chromatography–LC–MS, Fourier transform ion cyclotron resonance (FTICR) electrospray mass spectrometry of receptor–ligand complexes, affinity chromatography–mass spectrometry, and pulsed ultrafiltration mass spectrometry.
Title: Mass Spectrometry and Drug Discovery
Description:
AbstractCombinatorial chemistry and high‐throughput screening have become the primary tools of the medicinal chemist in an effort to accelerate the pace of drug discovery.
The goal of this new paradigm is to produce in a short time large numbers of synthetic organic compounds representing a great diversity of chemical structures through a process called combinatorial chemistry, and then quickly screen themin vitroagainst pharmacologically significant targets such as enzymes or receptors.
As a result, lead compounds might emerge from such combinatorial chemistry drug discovery programs in a few weeks instead of several years.
Although a variety of spectroscopic and chromatographic techniques are being used to support drug discovery in various capacities, only high performance liquid chromotography (HPLC) combined with mass spectrometry (LC‐MS and LC‐MS‐MS) is compatible with virtually all drug‐like molecules.
In addition to providing a universal means to characterize and distinguish drugs and drug candidates based on both molecular weight and structural features, mass spectrometry provides high throughput.
With the development of routine LC‐MS interfaces and ionization techniques such as electrospray and atmospheric pressure chemical ionization, mass spectrometry has also become an ideal HPLC detector for the analysis of combinatorial libraries.
Furthermore, a variety of mass spectrometry–based screening assays have been developed to address the need to screen complex mixtures of combinatorial compounds as well as to screen natural product extracts as a means of expanding the molecular diversity of drug leads.
The use of mass spectrometry in support of combinatorial library synthesis and purification is addressed in this chapter, as well as screening applications such as frontal affinity chromatography–mass spectrometry, gel permeation chromatography–LC–MS, Fourier transform ion cyclotron resonance (FTICR) electrospray mass spectrometry of receptor–ligand complexes, affinity chromatography–mass spectrometry, and pulsed ultrafiltration mass spectrometry.

Related Results

Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Desmoid-Type Fibromatosis of The Breast: A Case Series
Desmoid-Type Fibromatosis of The Breast: A Case Series
Abstract IntroductionDesmoid-type fibromatosis (DTF), also called aggressive fibromatosis, is a rare, benign, locally aggressive condition. Mammary DTF originates from fibroblasts ...
MSFC: A New Feature Construction Method for Accurate Diagnosis of Mass Spectrometry Data
MSFC: A New Feature Construction Method for Accurate Diagnosis of Mass Spectrometry Data
Abstract Background Mass spectrometry technology can realize dynamic detection of many complex matrix samples in a simple, rapid, compassionate, precise, and high-throughp...
Mass spectrometry of oligosaccharides
Mass spectrometry of oligosaccharides
Abstract I. Introduction 162  II. CHARACTERISTICS OF TANDEM MASS SPECTRA OF CARBOHYDRATES 163 A.  Ionization of Carbohydrates 163     1.  Electrospray Ionization (E...

Back to Top